Global Village
BioM Biotech Cluster Development GmbH
| Country: | Germany |
| Global Village: | Delegation of Munich (DE-BY) |
| Companies: | BioM Biotech Cluster Development GmbH FGK Clinical Research GmbH CfM Oskar Tropitzsch GmbH Cortex Discovery GmbH Iris Biotech GmbH Velvio GmbH |
| Roundtable discussion: | Tuesday, 23.04.2024, 15:15-15:45 “From Cutting-Edge Innovation to Strong Industrial Partnerships between Bavaria and Swiss Biotech Ecosystems” |
Company profile
Your gateway to the Bavarian biotech community
For over 25 years, BioM has been the network organization of the biotechnology industry in Munich and Bavaria. As a non-profit network organisation, BioM creates a unique ecosystem in medicine and biotechnology for innovation, growth and value creation in Bavaria. To achieve this, BioM connects all the relevant partners and support Bavarian biotech companies in every phase of their founding.
Website: https://www.bio-m.org/en.html
Further information
Follow us
FGK Clinical Research GmbH
FGK Clinical Research is a full-service CRO of an ideal size for cooperation with smaller and mid-sized biotech, medical device, or pharmaceutical companies. FGK, founded in 2002, has currently 230 employees, most of them located in our headquarters in Munich and our branch office in Berlin, Germany. Covering all phases and areas of clinical development, we have experience in every important medical indication. Broad knowledge of novel therapies completes our expertise.
Website: www.fgk-cro.com
CfM Oskar Tropitzsch GmbH
Cfm Oskar Tropitzsch GmbH assists the chemical, pharmaceutical and biotechnological industry in sourcing and producing chemical specialties. The core of our work is to support the product which our customer is looking for – with the right documentation, the correct quantity from mg to mt and proper quality and this not only for a one shot business but to support projects from RnD state up to commercial production. Finding the best solution for you!
Website: https://www.cfmot.de/en/
Cortex Discovery GmbH
Cortex has developed a deep learning-based technology with unprecedented accuracy in predicting molecule pharmacological properties. It is therapeutic field agnostic and lead to the discovery of lab-validated drug leads at negligible costs. The approach enables the parallelization of hit discovery with lead optimization, disrupting preclinical drug discovery.
Website: https://www.cortexdiscovery.com/
Iris Biotech GmbH
Empowering Peptide Innovation
Iris Biotech provides scientists in industry and academia with innovative and rare compounds, while also being a reliable partner for the supply of standard consumables. Our focus is on Peptide Chemistry, while we also have strong expertise in Drug Delivery, Life Sciences, and Linkerology.
Regarding Custom Synthesis, our skilled scientists and technicians offer profound expertise in the manufacturing of both simple and complex molecules.
Website: www.iris-biotech.de
Velvio GmbH
Velvio therapeutics renew brain and bone marrow stem cell populations to reactivate cell function, immune communication and milieu, to initiate neuronal regeneration. Velvio is developing it’s innovative compounds (Antisense Oligo`s, Filgrastim) in rare degenerative diseases (with orphan drug designation) for fast FDA / EMA approval: clinical efficacy in unmet medical need will be accompanied with extensive biomarker program. Filgrastim ready (clin. data!) for pivotal trial.
Website: https://velvio.com
